Avalo Therapeutics (AVTX) Capital Expenditures (2016 - 2023)
Avalo Therapeutics' Capital Expenditures was $158,000 in FY2023, up 66.3% from $95,000 in FY2022.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Capital Expenditures (2016 - 2023) Analysis & Trends
From FY2013 onward, Avalo Therapeutics has reported Capital Expenditures for 11 years.
- Capital Expenditures shows a five-year compound annual growth rate of -22.5% (FY2018 to FY2023).
- The FY2023 figure marks the highest annual Capital Expenditures since FY2019.
- Per Business Quant data, Capital Expenditures in earlier years was $95,000 in FY2022 (-15.9%), $113,000 in FY2021 (+79.4%), $63,000 in FY2020 (-76.0%) and $262,013 in FY2019 (-53.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 158,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Sep 30, 2021 | 81,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Sep 30, 2020 | 63,000.00 |
| Dec 31, 2019 | 2.00 |
| Sep 30, 2019 | 5,085.00 |
| Jun 30, 2019 | 90,957.00 |
| Mar 31, 2019 | 165,969.00 |
| Dec 31, 2018 | 499,358.00 |
| Sep 30, 2018 | 39,126.00 |
| Jun 30, 2018 | 6,707.00 |
| Mar 31, 2018 | 19,224.00 |
| Dec 31, 2017 | 15,335.00 |
| Sep 30, 2017 | 6,189.00 |
| Mar 31, 2017 | 1,801.00 |
| Dec 31, 2016 | 9,237.00 |
| Sep 30, 2016 | 6,489.00 |
API Access
Avalo Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();